Evidence map›Paper›PMID 40461935›Full record

ReviewInfectious diseases and therapy2025

Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination.

Jessica Presa, Ruth Carrico, Jaime E Fergie, Stephanie Hanenberg, Gary S Marshall, Kaitlyn Rivard, Jana Shaw, Gregory D Zimet, Paula Peyrani, Alejandro Cane

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Infectious diseases and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jessica PresaVaccines and Antivirals, Pfizer Inc, Collegeville, PA, USA. jessica.presa@pfizer.com.
Ruth CarricoDivision of Infectious Diseases, University of Louisville, Louisville, KY, USA.
Jaime E FergiePediatric Infectious Diseases Service, Driscoll Children's Hospital, Corpus Christi, TX, USA.
Stephanie HanenbergWellness Center, University of Colorado, Colorado Springs, CO, USA.
Gary S MarshallNorton Children's and the University of Louisville School of Medicine, Louisville, KY, USA.
Kaitlyn RivardDepartment of Pharmacy, Cleveland Clinic, Cleveland, OH, USA.
Jana ShawDepartment of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University, Syracuse, NY, USA.
Gregory D ZimetDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Paula PeyraniVaccines and Antivirals, Pfizer Inc, Collegeville, PA, USA.
Alejandro CaneVaccines and Antivirals, Pfizer Inc, Collegeville, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2022, experts convened under the name Advancing Strategies to Prevent Meningococcal Disease (ARTEMIS) to gather insights on issues related to invasive meningococcal disease (IMD) and meningococcal vaccination in the US. Discussions regarding successes, challenges, and future directions for the US meningococcal vaccination program are summarized. Current vaccination recommendations target adolescents/young adults (AYA), who are at increased risk of IMD. Suboptimal vaccination rates, particularly for meningococcal serogroup B disease, may stem from gaps in knowledge surrounding IMD and meningococcal vaccination among healthcare providers (HCPs), parents, and AYA; confusion among HCPs regarding the shared clinical decision-making recommendation for serogroup B vaccinations; demographic variables; and lack of preventive healthcare visits. ARTEMIS proposed strategies to address knowledge gaps and access barriers at the HCP, parent/AYA, and educational institution/policymaker levels. Alternative vaccination schedules using a recently approved MenABCWY vaccine that provides protection against all five major serogroups may simplify meningococcal vaccination and increase coverage.

Indexed as

AdolescentsHealthcare providersInvasive meningococcal diseaseMenABCWY vaccinePublic health policyShared clinical decision-makingUnited StatesVaccinationYoung adults

Identifiers

PMID40461935
PMCPMC12271012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.